Osaic Holdings
SYRS

Osaic Holdings’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Osaic Holdings’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-113
Closed -$24 – 7799
2024
Q4 		$24 Sell
113
-919
-89% -$1.1K ﹤0.01% 7320
2024
Q3 		$2.22K Hold
1,032
– – ﹤0.01% 6565
2024
Q2 		$5.32K Sell
1,032
-53
-5% -$278 ﹤0.01% 6141
2024
Q1 		$5.8K Buy
1,085
+2
+0.2% +$14 ﹤0.01% 6016
2023
Q4 		$8.44K Buy
1,083
+787
+266% +$2.7K ﹤0.01% 5916
2023
Q3 		$1.17K Buy
296
+73
+33% +$273 ﹤0.01% 6788
2023
Q2 		$702 Hold
223
– – ﹤0.01% 6975
2023
Q1 		$594 Hold
223
– – ﹤0.01% 7090
2022
Q4 		$1K Sell
223
-510
-70% -$2.21K ﹤0.01% 7004
2022
Q3 		$4K Buy
733
+90
+14% +$731 ﹤0.01% 6535
2022
Q2 		$6K Buy
643
+313
+95% +$2.93K ﹤0.01% 6424
2022
Q1 		$3K Buy
330
+86
+35% +$1.54K ﹤0.01% 6793
2021
Q4 		$8K Buy
244
+200
+455% +$8.1K ﹤0.01% 6423
2021
Q3 		$1K Hold
44
– – ﹤0.01% 7105
2021
Q2 		$3K Buy
44
+4
+10% +$237 ﹤0.01% 6639
2021
Q1 		$3K Buy
40
+30
+300% +$3.12K ﹤0.01% 6416
2020
Q4 		$1K Sell
10
-55
-85% -$5.02K ﹤0.01% 6296
2020
Q3 		$6K Hold
65
– – ﹤0.01% 5527
2020
Q2 		$7K Hold
65
– – ﹤0.01% 5351
2020
Q1 		$4K Buy
+65
New +$4.41K ﹤0.01% 5475

Other funds holding SYRS

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Osaic Holdings's SYRS Position: Q1 2025 in Review

Osaic Holdings sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2025, closing a stake of 113 shares — an estimated $24 sold.

Osaic Holdings first reported a position in SYRS in Q1 2020 and held it in 20 quarters. The position peaked at $8.44K in Q4 2023. 7 funds tracked by Wall St. Rank hold SYRS as of Q1 2025.

  • Osaic Holdings reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Osaic Holdings sold 113 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2025, an estimated $24.
  • Osaic Holdings first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 20 quarters.
  • Osaic Holdings's Syros Pharmaceuticals, Inc. Common Stock position peaked at $8.44K in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.